Literature DB >> 14762398

Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.

C Elso1, B Kumar, G Smyth, S Foote, E Handman.   

Abstract

Severity of disease caused by Leishmania major depends on the genetics of the host. Early induction of T helper cell type 1 (Th1)-type responses in resistant C57BL/6 mice and T helper cell type 2 (Th2) in susceptible BALB/c mice is thought to determine cure or disease respectively. We have mapped three loci that confer susceptibility or resistance upon congenic mice on the C57BL/6 or BALB/c backgrounds. Here we examine the histopathology and production of interleukin 4 (IL-4) and interferon gamma (IFN-gamma) in the skin and draining lymph nodes in the congenic and parental mice. We show an evolving granuloma with a staged infiltration of inflammatory cells, but no difference between the groups. As an indication of an early-polarised Th1/Th2 response we measured IFN-gamma and IL-4 in the lymph nodes and found no difference between any of the mice during the first 48 h. During infection, the level of IL-4 correlated with the lesion size, indicating that IL-4 reflects the disease severity rather than controls it. Considering this effect, B6.C(lmr1,lmr2) mice had similar cytokine levels to the parental C57BL/6 mice despite increased susceptibility and C.B6(lmr1,lmr2) were similar to BALB/c despite increased resistance. We conclude that the lmr loci affect disease severity by a mechanism independent of conventional helper T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762398     DOI: 10.1038/sj.gene.6364056

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  10 in total

1.  Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing.

Authors:  Anuratha Sakthianandeswaren; Joan M Curtis; Colleen Elso; Beena Kumar; Tracey M Baldwin; Sash Lopaticki; Lukasz Kedzierski; Gordon K Smyth; Simon J Foote; Emanuela Handman
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

2.  The wound repair response controls outcome to cutaneous leishmaniasis.

Authors:  Anuratha Sakthianandeswaren; Colleen M Elso; Ken Simpson; Joan M Curtis; Beena Kumar; Terence P Speed; Emanuela Handman; Simon J Foote
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-13       Impact factor: 11.205

3.  Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1.

Authors:  James N Arnold; Lukasz Magiera; Matthew Kraman; Douglas T Fearon
Journal:  Cancer Immunol Res       Date:  2013-11-18       Impact factor: 11.151

4.  Canine cutaneous leishmaniasis.

Authors:  F Sasani; J Javanbakht; R Samani; D Shirani
Journal:  J Parasit Dis       Date:  2014-03-12

5.  Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.

Authors:  Ghassem Solgi; Amina Kariminia; Khossor Abdi; Majid Darabi; Behnaz Ghareghozloo
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

6.  Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice.

Authors:  Cristina R Carter; James P Whitcomb; Jessica A Campbell; Rami M Mukbel; Mary Ann McDowell
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

7.  A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan.

Authors:  Hans-Christian Stahl; Faridullah Ahmadi; Ulrike Schleicher; Rainer Sauerborn; Justo Lorenzo Bermejo; Mohammed Latif Amirih; Ibrahim Sakhayee; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

8.  IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis.

Authors:  Ciara Gimblet; Michael A Loesche; Lucas Carvalho; Edgar M Carvalho; Elizabeth A Grice; David Artis; Phillip Scott
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

Review 9.  Lessons from other diseases: granulomatous inflammation in leishmaniasis.

Authors:  Paul M Kaye; Lynette Beattie
Journal:  Semin Immunopathol       Date:  2015-12-17       Impact factor: 9.623

10.  Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response.

Authors:  Phillip D Fromm; Jessica C Kling; Annika Remke; Christian Bogdan; Heinrich Körner
Journal:  Front Microbiol       Date:  2016-01-22       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.